Brief: Immix Biopharma Subsidiary Nexcella Appoints Jeffrey H. Cooper, Former Chief Financial Officer Of Biomarin, To Board Of Directors
20/06/2023 16:17
June 20 (Reuters) - Immix Biopharma Inc-
* IMMIX BIOPHARMA SUBSIDIARY NEXCELLA APPOINTS JEFFREY H.
COOPER,
FORMER CHIEF FINANCIAL OFFICER OF BIOMARIN, TO BOARD OF
DIRECTORS
Source text for Eikon: ID:nGNX4s6W66
Further company coverage: IMMX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Immix Biopharma
See all newsBrief: Immix Biopharma Announces Closing Of $125 Million Underwritten Offering Of Common Stock
US RESEARCH ROUNDUP-Alnylam Pharmaceuticals, Carvana, MongoDB
Brief: Immix Biopharma Announces Pricing Of $125 Million Underwritten Offering Of Common Stock
Brief: Immix Biopharma Announces 89% Complete Response Rate At Interim Update Across All Nexicart-2 Patients, With Mrd-Negativity Indicating Potential To Reach Up To 98% Complete Response Rate
Immix Biopharma, Inc. reports results for the quarter ended June 30 - Earnings Summary